Prevalence and risk of complications in untreated patients with adult growth hormone deficiency

Untreated patients with AGHD have a higher prevalence of metabolic complications than the general population despite no difference in their related risk factors. Given the low use of GHRT in this study, comprehensive treatment approaches that include GHRT need to be considered to alleviate the risk of complications.

Authors

Satoshi Tsuboi (ORCID: https://orcid.org/0000-0003-3164-0222)
Takaaki Endo (ORCID: https://orcid.org/0009-0005-6146-6394)
Hidenori Fukuoka (ORCID: https://orcid.org/0000-0001-9255-653X)
Shingo Fujio (ORCID: https://orcid.org/0000-0001-8813-5038)

Institutions

Kagoshima University (JP)
Kobe University Hospital (JP)
Novo Nordisk (Italy) (IT)

Publication Details

Journal: Pituitary
Published: 2025-02-18
DOI: https://doi.org/10.1007/s11102-025-01500-9
Citations: 7
Primary Topic: Growth Hormone and Insulin-like Growth Factors
Type: article
Field-Weighted Citation Impact: 9.06

Funders

Novo Nordisk
Novo Nordisk Pharma

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Prevalence and risk of complications in untreated patients with adult growth hormone deficiency

Satoshi Tsuboi, Takaaki Endo, Hidenori Fukuoka, Shingo Fujio

Feb 18, 2025

7 citations

Pituitary

Growth Hormone and Insulin-like Growth Factors

9.06

article

Prevalence and risk of complications in untreated patients with adult growth hormone deficiency

Satoshi Tsuboi, Takaaki Endo, Hidenori Fukuoka, Shingo Fujio

February 18, 2025article en

7 citations

Abstract

Untreated patients with AGHD have a higher prevalence of metabolic complications than the general population despite no difference in their related risk factors. Given the low use of GHRT in this study, comprehensive treatment approaches that include GHRT need to be considered to alleviate the risk of complications.

PituitaryVol. 28(2)

Kagoshima University (JP), Kobe University Hospital (JP), Novo Nordisk (Italy) (IT)

Novo Nordisk, Novo Nordisk Pharma

Good health and well-being

Openalex Percentile: Top 2%

Growth Hormone and Insulin-like Growth Factors

9.06

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevalence and risk of complications in untreated patients with adult growth hormone deficiency — Satoshi Tsuboi, Takaaki Endo, et al. · Pituitary (2025) | TGRS Research Map | TGRS